Validates the use of the RAPID score for predicting mortality in pleural infections, directly informing the management of patients undergoing pleural interventions like chest tubes and medical thoracoscopy.
Abstract
Deng et al. [1] report a multicentre randomised trial comparing ultrasonic elastography-guided pleural biopsy (UEPB) with traditional thoracic ultrasound-guided pleural biopsy (TUSPB) for diagnosing malignant pleural effusion (MPE). The study addresses an important clinical problem, and the authors are commended for this head-to-head comparison. However, several aspects of reporting would help readers better judge the robustness and validity of the findings.
Keep reading
N opens the next oneUltrasound estimation of pleural fluid volume is a core procedural skill for thoracentesis and chest tube placement, making this directly relevant to IP practice.
Directly impacts pleural management and staging by maximizing the diagnostic yield of routine thoracentesis for molecular testing in malignancy.
Pleural fluid obtained during thoracentesis or medical thoracoscopy should be preserved for cfDNA molecular testing when tissue is limited.
Relevant to pleural disease management and post-procedural care of trapped or non-expandable lungs.
Provides useful risk stratification tools for managing secondary spontaneous pneumothorax patients who often require IP intervention.